SCHEMBL10460171

SCHEMBL10460171

Cc1cc(Cl)ccc1OCC(O)(Cn1cncn1)C(C)(C)CF

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 5/20 0.47
ALDH1A1 P00352 2/20 0.47
KMT2A Q03164 2/20 0.42
POLB P06746 1/20 0.41
CYP2C9 P11712 4/20 0.39
CYP2C19 P33261 4/20 0.39
GAA P10253 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2D6 P10635 2/20 0.39
KDM4E B2RXH2 2/20 0.39
KCNH2 Q12809 1/20 0.39
LMNA P02545 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
NPC1 O15118 2/20 0.36
HPGD P15428 2/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
SSTR4 P31391 1/20 0.36
TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10634281 0.91 CYP3A4 (0.48) CYP3A4ALDH1A1KMT2APOLBCYP2C9
SCHEMBL9634196 0.89 ALDH1A1 (0.57) CYP3A4ALDH1A1KMT2APOLBGAA
SCHEMBL10631729 0.84 ALDH1A1 (0.55) CYP3A4ALDH1A1KMT2APOLBCYP2C9
SCHEMBL10631803 0.82 CYP3A4 (0.48) CYP3A4ALDH1A1KMT2APOLBCYP2C9
SCHEMBL10875656 0.81 POLB (0.42) CYP3A4ALDH1A1KMT2APOLBCYP2C9
SCHEMBL10366188 0.80 ALDH1A1 (0.58) CYP3A4ALDH1A1KMT2APOLBCYP2C9
SCHEMBL10461548 0.78 CYP3A4 (0.42) CYP3A4ALDH1A1KMT2ACYP2C9CYP2C19
SCHEMBL9663100 0.78 POLB (0.42) CYP3A4ALDH1A1KMT2APOLBCYP2C9
SCHEMBL9633868 0.78 ALDH1A1 (0.42) CYP3A4ALDH1A1KMT2APOLBCYP2C9
SCHEMBL10861689 0.77 CYP3A4 (0.41) CYP3A4ALDH1A1KMT2APOLBCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4904682-A Treating mycoses with triazolylalkanols BAYER AKTIENGESELLSCHAFT (DE) 1990-02-27 US disclosed
EP-0313983-A2 Use of triazolyl alkanols in the treatment of illnesses BAYER AG (DE) 1989-05-03 EP disclosed